Inter-observer variation in gross tumour volume delineation of oesophageal cancer on MR, CT and PET/CT
References
- World Health Organization International Agency for Research on Cancer (IARC). GLOBOCAN 2020: Estimated cancer incidence, mortality and prevalence worldwide in 2020. [internet]. [cited 2024 Jan 20]. Available at:
http://globocan.iarc.fr/ - Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol 2020; 13: 1010–21. doi: 10.1007/s12328-020-01237-x
- Stahl M, Mariette C, Haustermans K, Cervantes A, Arnold D. ESMO Guidelines Working Group. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl 6): vi51–6. doi: 10.1093/annonc/mdt342
- Eyck BM, Van Lanschot JJB, Hulshof MCCM, van der Wilk BJ, Shapiro J, van Hagen P, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS Trial. J Clin Oncol 2021; 39: 1995–2004. doi: 10.1200/JCO.20.03614
- van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074–84. doi: 10.1056/NEJMoa1112088
- Chan KKW, Saluja R, Santos KD, Lien K, Shah K, Cramarossa G, et al. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: a network meta-analysis. Int J Cancer 2018; 143: 430–37. doi: 10.1002/ijc.31312
- Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8: 545–53. doi: 10.1016/S1470-2045(07)70172-9
- Beaton L, Bandula S, Gaze MN, Sharma RA. How rapid advances in imaging are defining the future of precision radiation oncology. Br J Cancer 2019; 120: 779–90. doi: 10.1038/s41416-019-0412-y
- Sillah K, Williams LR, Laasch HU, Saleem A, Watkins G, Pritchard SA, et al. Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning. World J Gastrointest Oncol 2010; 2: 197–204. doi: 10.4251/wjgo.v2.i4.197
- Decazes P, Hinault P, Veresezan O, Thureau S, Gouel P, Vera P. Trimodality PET/CT/MRI and radiotherapy: a mini-review. Front Oncol 2021; 10: 1–9. doi: 10.3389/fonc.2020.614008
- Lambrecht M, Haustermans K. Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors. Radiother Oncol 2010; 96: 339–46. doi: 10.1016/j.radonc.2010.07.019
- Lu J, Sun XD, Yang X, Ang XY, Qin Q, Zhu HC, et al. Impact of PET/CT on radiation treatment in patients with esophageal cancer: a systematic review. Crit Rev Oncol Hematol 2016; 107: 128–37. doi: 10.1016/j.critrevonc.2016.08.015
- Jiang C, Chen Y, Zhu Y, Xu Y. Systematic review and meta-analysis of the accuracy of 18F-FDG PET/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma. J Thorac Dis 2018; 10: 6066–76. doi: 10.21037/jtd.2018.10.57
- Garcia B, Goodman KA, Cambridge L, Dunphy M, Wu AJ. Distribution of FDG-avid nodes in esophageal cancer: Implications for radiotherapy target delineation. Radiat Oncol 2016; 11: 1–8. doi: 10.1186/s13014-016-0731-6
- Machiels M, Wouterse SJ, Geijsen ED, van Os RM, Bennink RJ, van Laarhoven HW, et al. Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy. J Med Imaging Radiat Oncol 2016; 60: 520–27. doi: 10.1111/1754-9485.12474
- Münch S, Marr L, Feuerecker B, Dapper H, Braren R, Combs SE, et al. Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients. Strahlentherapie Onkol 2020; 196: 787–94. doi: 10.1007/s00066-020-01630-y
- Thomas L, Lapa C, Bundschuh RA, Polat B, Sonke JJ, Guckenberger M. Tumour delineation in oesophageal cancer – a prospective study of delineation in PET and CT with and without endoscopically placed clip markers. Radiother Oncol 2015; 116: 269–75. doi: 10.1016/j.radonc.2015.07.007
- Mamede M, El Fakhri G, Abreu-E-Lima P, Andler W, Nosé V, Gerbaudo VH. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med 2007; 21: 553–62. doi: 10.1007/s12149-007-0040-0
- Han D, Yu J, Yu Y, Zhang G, Zhong X, Lu J, et al. Comparison of 18F-Fluorothymidine and 18F-Fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus. Int J Radiat Oncol Biol Phys 2010; 76: 1235–41. doi: 10.1016/j.ijrobp.2009.07.1681
- Zhong X, Yu J, Zhang B, Mu D, Zhang W, Li D, et al. Using 18F-Fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009; 73: 136–41. doi: 10.1016/j.ijrobp.2008.04.015
- Nowee ME, Voncken FEM, Kotte ANTJ, Goense L, van Rossum PSN, van Lier ALHMW, et al. Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: a nationwide study. Clin Transl Radiat Oncol 2018; 14: 33–9. doi: 10.1016/j.ctro.2018.10.003
- Toya R, Matsuyama T, Saito T, Imuta M, Shiraishi S, Fukugawa Y, et al. Impact of hybrid FDG-PET/CT on gross tumor volume definition of cervical esophageal cancer: reducing interobserver variation. J Radiat Res 2019; 60: 348–52. doi: 10.1093/jrr/rrz004
- Vesprini D, Ung Y, Dinniwell R, Breen S, Cheung F, Grabarz D, et al. Improving observer variability in target delineation for gastro-oesophageal cancer – the role of 18Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography. Clin Oncol 2008; 20: 631–38. doi: 10.1016/j.clon.2008.06.004
- Schreurs LM, Busz DM, Paardekooper GM, Beukema JC, Jager PL, Van der Jagt EJ, et al. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability. Dis Esophagus 2010; 23: 493–501. doi: 10.1111/j.1442-2050.2009.01044.x
- Li F, Li Y, Wang X, Zhang Y, Liu X, Liu S, et al. Inter-observer and Intra-observer variability in gross tumor volume delineation of primary esophageal carcinomas based on different combinations of diagnostic multimodal images. Front Oncol 2022; 12: 1–10. doi: 10.3389/fonc.2022.817413
- Shi J, Li J, Li F, Zhang Y, Guo Y, Wang W, et al. Comparison of the gross target volumes based on diagnostic PET/CT for primary esophageal cancer. Front Oncol 2021; 11: 1–10. doi: 10.3389/fonc.2021.550100
- van Rossum PSN, Van Lier ALHMW, Lips IM, Meijer GJ, Reerink O, van Vulpen M, et al. Imaging of oesophageal cancer with FDG-PET/CT and MRI. Clin Radiol 2015; 70: 81–95. doi: 10.1016/j.crad.2014.07.017
- Hou DL, Shi GF, Gao XS, Asaumi J, Li XY, Liu H, et al. Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma. Radiat Oncol 2013; 8: 169. doi: 10.1186/1748-717X-8-169
- Vollenbrock SE, Nowee ME, Voncken FEM, Kotte ANTJ, Goense L, van Rossum PSN, et al. Gross tumor delineation in esophageal cancer on MRI compared with 18F-FDG-PET/CT. Adv Radiat Oncol 2019; 4: 596–604. doi: 10.1016/j.adro.2019.04.004
- Kouwenhoven E, Giezen M, Struikmans H. Measuring the similarity of target volume delineations independent of the number of observers. Phys Med Biol 2009; 54: 2863–73. doi: 10.1088/0031-9155/54/9/018
- Warfield SK, Zou KH, Wells WM. Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation. IEEE Trans Med Imaging 2004; 23: 903–21. doi: 10.1109/TMI.2004.828354
- Petrič P, Hudej R, Rogelj P, Blas M, Tanderup K, Fidarova E, et al. Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study. Radiother Oncol 2013; 107: 6–12. doi: 10.1016/j.radonc.2013.01.014
- Rogelj P, Hudej R, Petric P. Distance deviation measure of contouring variability. Radiol Oncol 2013; 47: 86–96. doi: 10.2478/raon-2013-0005
- Šegedin B. [Objective evaluation of the impact of learning on differences in the contouring of target volumes in radiotherapy]. [Slovenian]. Doctoral thesis. Ljubljana: University of Ljubljana. Medical Faculty; 2016.
- Machiels M, Jin P, van Hooft JE, Gurney-Champion OJ, Jelvehgaran P, Geijsen ED, et al. Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers. Acta Oncol 2019; 58: 943–50. doi: 10.1080/0284186X.2019.1588991
- Wu YW, Tseng PH, Lee YC, Wang SY, Chiu HM, Tu CH, et al. Association of esophageal inflammation, obesity and gastroesophageal reflux disease: From FDG PET/CT perspective. PLoS One 2014; 9: e92001. doi: 10.1371/journal.pone.0092001
Language: English
Page range: 580 - 587
Submitted on: May 11, 2024
Accepted on: Jul 25, 2024
Published on: Oct 4, 2024
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2024 Ajra Secerov-Ermenc, Primoz Peterlin, Franc Anderluh, Jasna But-Hadzic, Ana Jeromen-Peressutti, Vaneja Velenik, Barbara Segedin, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.